Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Mol Cancer Ther. 2013 Oct 29;13(2):528–539. doi: 10.1158/1535-7163.MCT-13-0646

Figure 2.

Figure 2

Time-to-tumor recurrence (TTR) by PLS3rs6643869 and LCP14941543 in Austrian cohort (Validation set) stage II/III CRC patients treated with 5-fluorouracil (5-FU)-basedchemotherapy.